Overview
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA, discovered in 2015 by Pinchas Cohen at USC. It is one of the most exciting exercise-mimetic candidates in aging research: it regulates metabolism, increases during exercise, and in mice it produces effects strikingly similar to endurance training.
Human interest exploded after studies showed MOTS-c levels correlate with physical capacity and decline with age.
How It Works
MOTS-c activates AMPK — the same master metabolic switch triggered by exercise, fasting and metformin. Under metabolic stress it translocates to the cell nucleus and directly regulates gene expression, a remarkable behavior for a mitochondrial peptide.
The exercise connection
Exercise acutely raises MOTS-c levels in humans, and the peptide appears to mediate part of the metabolic benefit of training. In mice, MOTS-c administration improves glucose tolerance, prevents diet-induced obesity, and increases endurance capacity and late-life physical function.
Key Benefits
Metabolic health — improved insulin sensitivity and glucose handling in animal models.
Endurance capacity — mice on MOTS-c run significantly longer; the exercise-mimetic claim rests here.
Fat metabolism — protection against diet-induced obesity in rodents.
Healthy aging signals — improved physical function in aged mice; human levels correlate with fitness.
Side Effects & Considerations
Human data is limited to observational studies and early-phase work on related compounds. No completed human trials of MOTS-c administration for performance or aging exist, so dosing and long-term safety are unknown.
The honest framing
MOTS-c is what people hope it is in mice. Whether that translates to humans is an open question being actively researched. Meanwhile, the intervention that reliably raises your MOTS-c — exercise — is free, proven, and comes with every other benefit too. Grey-market use is a bet on translation that has not yet been validated. Not approved for human use.
Dosage protocols
| Protocol | Dosage | Frequency | Duration | Notes |
|---|---|---|---|---|
| Community protocol (anecdotal) | 5-10 mg | 1-3 times weekly | 4-8 weeks | No human dosing studies exist. Often used before training in community protocols. |
Warnings
No completed human trials. Exercise raises MOTS-c naturally and is proven. Not approved for human use.